A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19
Richard S. Hotchkiss, Jane Blood, Marcel R.M. van den Brink, Michel Morre et al.
Citations
13 citations
Journal
JCI Insight
Topics
COVID-19 Clinical Research Studies
Field-Weighted Citation Impact (FWCI)
18.15
article
A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19
Richard S. Hotchkiss, Jane Blood, Marcel R.M. van den Brink, Michel Morre, James P. Bosanquet, Manu Shankar‐Hari, Andrew H. Walton, Frederique Berbille, Cassian Yee, Robert Martin, Vidula Vachharajani, Thomas Daix, Teresa Blood, David A. Striker, Robin Jeannet, Reinaldo Salomão, Felipe Dal‐Pizzol, Lyle L. Moldawer, Kenneth E. Remy, Scott C. Brakenridge, Cristina Gutiérrez, Bruno François, Nitin J. Anand, Stephen Pastores, Georg Auzinger
article en
13 citations
Abstract
No abstract available for this paper.
Publication Tag
JCI InsightVol. 10(6)
Institutions
Cleveland Clinic (US), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), Inserm (FR), Washington University in St. Louis (US), Missouri Baptist Medical Center (US), University of Florida (US), MRC Centre for Regenerative Medicine (GB), City of Hope (US), Centre Hospitalier Universitaire de Limoges (FR), Instituto de Cardiologia de Santa Catarina (BR), Centre for Inflammation Research (GB), King's College Hospital (GB), Hospital São Paulo (BR), Universidade do Extremo Sul Catarinense (BR), Universidade Federal de São Paulo (BR), Florida College (US), University of Edinburgh (GB)
Funders
Cancer Research Institute, Washington University in St. Louis, Case Western Reserve University, National Institutes of Health, National Institute of General Medical Sciences